David Diamond

Insider Reports History

Location
Agoura Hills, CA
Signature
/s/ Shaun Bagai, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Diamond:

Form 4 holding Director

Oncotelic Therapeutics, Inc.

Security class
Stock Options
Shares / value
451,467
Estimated value
Report date
08 Jul 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

RenovoRx, Inc.

Security class
Stock Options (right to buy)
Shares / value
25,099
Estimated value
Report date
01 Oct 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by David Diamond

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .